跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
达必妥 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Dupilumab Injection
Approved
生物制品
Dupilumab Injection
SANOFI WINTHROP INDUSTRIE
🇨🇳 National Medical Products Administration
Approval Date
Jan 30, 2026
Approval ID
8CYmWbQUpZT
Company
SANOFI WINTHROP INDUSTRIE
Type
生物制品
Approval Details
Approval Id
8CYmWbQUpZT
Approval Number
国药准字SJ20210024
Generic Name
度普利尤单抗注射液
Generic Name En
Dupilumab Injection
Trade Name
达必妥
Drug Type
生物制品
Dosage Form
注射剂
Strength
200mg(1.14mL)/支(预充式注射器)
Reg Date
2026-01-30
Expired Date
2031-01-29
Company Name
SANOFI WINTHROP INDUSTRIE
Production Company Name
SANOFI WINTHROP INDUSTRIE
Company Detail Path
/organization/sanofi-winthrop-industrie
Production Company Detail Path
/organization/sanofi-winthrop-industrie
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jan 30, 2026
Approval ID
8CYmWbQUpZT
Type
生物制品
Back to NMPA Approvals